Society of Infectious Diseases Pharmacists

Society of Infectious Diseases Pharmacists
Name	Society of Infectious Diseases Pharmacists
Formation	1990s
Type	Professional association
Headquarters	United States
Region served	International
Membership	Pharmacists
Leader title	President

Contents

Society of Infectious Diseases Pharmacists

The Society of Infectious Diseases Pharmacists is a professional association for pharmacists specializing in infectious diseases, antimicrobial stewardship, and hospital-based therapeutics. The organization interacts with major institutions such as Centers for Disease Control and Prevention, World Health Organization, Food and Drug Administration, National Institutes of Health, and collaborates with professional bodies like American Society of Health-System Pharmacists, Infectious Diseases Society of America, European Society of Clinical Microbiology and Infectious Diseases, Association of American Medical Colleges, and American Medical Association to influence clinical practice, policy, and education.

History

Founded in the late 20th century, the society emerged amid rising concern over antimicrobial resistance highlighted by events and stakeholders including Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci, and surveillance networks such as PulseNet and Global Antimicrobial Resistance Surveillance System. Early leadership included clinicians and pharmacists with links to institutions like Johns Hopkins Hospital, Mayo Clinic, Massachusetts General Hospital, Cleveland Clinic, and Stanford Health Care. The society's evolution tracked major public health moments including responses to outbreaks like Severe Acute Respiratory Syndrome, H1N1 influenza pandemic, and Ebola virus epidemic in West Africa while interacting with policy milestones like the Affordable Care Act and initiatives from Centers for Medicare & Medicaid Services.

The society's mission aligns with enhancing patient care through optimal antimicrobial use and stewardship, mirroring priorities set by organizations such as Joint Commission, World Health Organization, Centers for Disease Control and Prevention, National Quality Forum, and American College of Clinical Pharmacy. Objectives include developing competency frameworks comparable to those from Royal Pharmaceutical Society, producing guidance consistent with standards from Clinical and Laboratory Standards Institute, and supporting interdisciplinary models seen in institutions like University of California, San Francisco Medical Center and University of Pennsylvania Health System.

Membership comprises pharmacists from settings spanning academic centers like Harvard Medical School, University of Toronto, and University of Oxford, to community hospitals and public health agencies such as Public Health England and New York City Department of Health and Mental Hygiene. Governance structures reflect nonprofit models used by organizations such as American Pharmacists Association, American Society of Health-System Pharmacists, and Infectious Diseases Society of America, with elected officers including a President, Treasurer, and Board of Directors, and committees analogous to those in National Academy of Medicine and Institute of Medicine.

The society provides continuing education and certification support tied to credentials like Board of Pharmacy Specialties recognition and training crosswalks similar to programs at Centers for Disease Control and Prevention and National Institutes of Health. Educational offerings draw on methods used by Massachusetts General Hospital clinical courses, Mayo Clinic post-graduate programs, and online platforms akin to Coursera partnerships seen in other medical societies. It also collaborates with universities such as University of Washington, University of Michigan, University of California, San Diego, and University of British Columbia to advance curricula and fellowships.

The society contributes to research consortia and guideline development alongside bodies like Infectious Diseases Society of America, European Centre for Disease Prevention and Control, National Institutes of Health, and World Health Organization. It issues recommendations that interact with regulatory frameworks from Food and Drug Administration, reimbursement policies influenced by Centers for Medicare & Medicaid Services, and quality measures endorsed by The Joint Commission. Advocacy efforts have engaged legislative processes in venues such as United States Congress and have aligned with global initiatives from Global Antibiotic Research and Development Partnership and Wellcome Trust.

Annual meetings and scientific sessions mirror formats used by Infectious Diseases Society of America and European Society of Clinical Microbiology and Infectious Diseases, attracting speakers from institutions like Johns Hopkins Bloomberg School of Public Health, Columbia University Irving Medical Center, University College London, and Karolinska Institutet. The society publishes practice resources, position papers, and continuing education materials comparable to outputs from Clinical Infectious Diseases, The Lancet Infectious Diseases, Journal of Antimicrobial Chemotherapy, and Antimicrobial Agents and Chemotherapy, and collaborates with editorial boards linked to publishers such as Oxford University Press and Elsevier.

Category:Medical associations Category:Pharmacy organizations Category:Infectious disease organizations